Protagenic Therapeutics, Inc.\new Bridge Loan
Protagenic Therapeutics, Inc.\new (PTIX) had Bridge Loan of $73.50 thousand as of 2016-03-31, per its 10-Q filed 2016-07-25.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Debt, Current
us-gaap:BridgeLoan · last filed 2017-05-08
- 2016-03-31: Bridge Loan $73.50K.
- 2015-12-31: Bridge Loan $399.10K.
- 2014-12-31: Bridge Loan $0.00.
| Period end | Bridge Loan |
|---|---|
| 2016-03-31 | $73.50K 10-Q · filed 2016-07-25 |
| 2015-12-31 | $399.10K 10-K/A · filed 2017-05-08 |
| 2014-12-31 | $0.00 8-K/A · filed 2016-07-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |